Endocrine, Metabolic And Immune Disorders - Drug Targets: Impact Factor, Indexing, Publication Time & Fees

---

The Endocrine, Metabolic And Immune Disorders - Drug Targets is reputed journal publishes research related to Medicine. The ISSN of the journal is 22123873.

Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.

Endocrine, Metabolic And Immune Disorders - Drug Targets: Details

Journal Title	Endocrine, Metabolic and Immune Disorders - Drug Targets
Publisher	Bentham Science Publishers B.V.
Publication Country	United Arab Emirates
ISSN	22123873
Publication Area	Endocrinology, Diabetes and Metabolism (Q3); Immunology and Allergy (Q3)
Publication Language
Review Process
Scopus Indexed	Yes

Journal Quartile

The Endocrine, Metabolic And Immune Disorders - Drug Targets is ranked in Q3.

Indexing

The Endocrine, Metabolic And Immune Disorders - Drug Targets is indexed in: Scopus, PubMed, Embase, UGC CARE Group 2.

Similiar journals to publish

---

Endocrine, Metabolic and Immune Disorders - Drug Targets

ISSN: 22123873
Publisher: Bentham Science Publishers B.V.
Journal Scope: Medicine

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS

ISSN: 2212-3873
Publisher: BENTHAM SCIENCE PUBL LTD
Journal Scope:

Reviews in Endocrine and Metabolic Disorders

ISSN: 15732606
Publisher: Springer Netherlands
Journal Scope: Biochemistry, Genetics and Molecular Biology; Medicine

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

ISSN: 1573-2606
Publisher: SPRINGER
Journal Scope:

CNS and Neurological Disorders - Drug Targets

ISSN: 19963181
Publisher: Bentham Science Publishers B.V.
Journal Scope: Medicine; Neuroscience; Pharmacology, Toxicology and Pharmaceutics

Cardiovascular and Hematological Disorders - Drug Targets

ISSN: 22124063
Publisher: Bentham Science Publishers B.V.
Journal Scope: Biochemistry, Genetics and Molecular Biology; Medicine; Pharmacology, Toxicology and Pharmaceutics